Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
filingDate |
1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1995-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-950013521-A |
titleOfInvention |
Topical Formulations Including Serine Protease Inhibitors |
abstract |
The present invention relates to a contractile composition for topical treatment of a mammal having a skin disease. The composition comprises an effective amount of a protease inhibitor and a carrier, the effective amount of quaternary ammonium salts in an effective concentration to increase the penetration of the protease inhibitor in the skin. In addition, such compositions may comprise ethoxylated nonylphenol. |
priorityDate |
1993-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |